Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…
Ten athlete ambassadors engaged in preventing competition manipulation announced
10 September 2025 – Ten athletes from every continent and 10 different…
Mohamed bin Zayed University of Artificial Intelligence begins new academic year with largest-ever cohort of 400+ students
ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ -- Mohamed bin Zayed University of…
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
NULISAseqâ„¢ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker…
SPJIMR’s PGDM Class of 2027 celebrates leadership, diversity, and purpose
New cohort embarks on a transformative journey in management and leadership MUMBAI,…
Admissions now open: SPJIMR’s Global Management Programme for future global leaders
From Mumbai to the world—experience education through a dual-campus global management programme MUMBAI,…